Enhanced efficacy of combined temozolomide and bromodomain inhibitor therapy for gliomas using targeted nanoparticles
The blood-brain barrier often limits effective delivery of treatments for glioblastoma . In this study, the authors develop transferrin-functionalized nanoparticles able to traverse the intact blood-brain barrier and deliver combination temozolomide and bromodomain inhibitor therapy to glioma-bear...
Guardado en:
Autores principales: | Fred C. Lam, Stephen W. Morton, Jeffrey Wyckoff, Tu-Lan Vu Han, Mun Kyung Hwang, Amanda Maffa, Elena Balkanska-Sinclair, Michael B Yaffe, Scott R Floyd, Paula T Hammond |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7b4a074c2e9340cbb338535cafd8e632 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Combined Delivery of Temozolomide and siPLK1 Using Targeted Nanoparticles to Enhance Temozolomide Sensitivity in Glioma
por: Shi H, et al.
Publicado: (2020) -
BRD4 prevents the accumulation of R-loops and protects against transcription–replication collision events and DNA damage
por: Fred C. Lam, et al.
Publicado: (2020) -
Temozolomide arrests glioma growth and normalizes intratumoral extracellular pH
por: Jyotsna U. Rao, et al.
Publicado: (2017) -
Codelivery of temozolomide and siRNA with polymeric nanocarrier for effective glioma treatment
por: Peng Y, et al.
Publicado: (2018) -
Temozolomide is additive with cytotoxic effect of irradiation in canine glioma cell lines
por: Nina Simona Tresch, et al.
Publicado: (2021)